<乌鸦传媒>Gene Tx Shows Sustained Bleeding Control in Severe Hemophilia A at 2 Years Model predicts valoctocogene roxaparvovec could maintain mild hemophilia levels for 5 years Feb 23, 2023
<乌鸦传媒>New Class of Factor VIII Replacement Therapy Prevents Bleeds in Severe Hemophilia A Weekly dosing with efanesoctocog alfa reduced annualized bleeding rate by 77% Jan 25, 2023
<乌鸦传媒>FDA OKs First Gene Therapy for Hemophilia B Hemgenix reduced rate of annual bleeds, eliminated need for factor IX prophylaxis therapy Nov 22, 2022
<乌鸦传媒>Year in Review: Hemophilia Gene therapy continues to show promise in clinical trials, but is it ready for the clinic? Nov 17, 2022
<乌鸦传媒>'Unparalleled Times' in Hematology, but Workforce Issues Persist "This is the most exciting time ever" to be a hematologist, says ASH President Jane Winter, MD Sep 26, 2022 video
<乌鸦传媒>Lessons From a Lifelong Patient Turned Oncologist Eric Winer, MD, talks about how growing up with hemophilia helped him connect with patients Aug 02, 2022 podcast
<乌鸦传媒>Fitusiran Prophylaxis Cuts Bleeding in Hemophilia A/B Monthly infusion vs on-demand bypassing agents effective in patients with or without inhibitors Dec 14, 2021
<乌鸦传媒>Liver Toxicity in Gene Therapy Trials Could Merit Stricter Entry Criteria FDA panel weighs in on lower vector doses and role of animal studies Sep 03, 2021
<乌鸦传媒>Whole-Genome Sequencing Makes a Case in Leukemia Study More actionable alterations detected in myeloid malignancies versus cytogenetics Mar 10, 2021
<乌鸦传媒>Gene Therapy Stops Bleeding in Hemophilia Single injection had durable effectiveness, study showed Dec 08, 2020
<乌鸦传媒>Severe Nosebleeds More Common With Hypertension Korean study supports link between hypertension and epistaxis Sep 10, 2020
<乌鸦传媒>MSK Cancer Alliance: Mainly About Medicine Bi-directional relationship strengthens regional cancer care Mar 11, 2017
<乌鸦传媒>Combo Boosts PFS in Tough-to-Treat Myeloma Recurrent or relapsed disease susceptible to daratumumab-bortezomib-dexamethasone Jun 07, 2016
